Table 3. Multivariate COX regression analysis to assess independent correlated of adverse events following PCI for CHD during follow-up.
| Factors | B | SE | Waldχ2 | P | HR (95%CI) |
|---|---|---|---|---|---|
| Smoking | 0.221 | 0.331 | 11.283 | 0.021 | 1.24 (1.17–2.31) |
| BMI ≥ 28 kg/m2 | 0.340 | 0.461 | 10.814 | 0.026 | 1.40 (1.19–2.74) |
| LDL-C ≥ 3.37 mmol/l | 0.523 | 0.236 | 12.369 | 0.011 | 1.69 (1.22–3.45) |
| Hc-CRP, mg/dl | 1.197 | 0.393 | 20.124 | 0.000 | 3.31 (1.24–3.89) |
| Creatinine, μmol/l | 0.528 | 0.213 | 11.478 | 0.010 | 1.71 (1.17–2.65) |
| lncRNA-Ang362 (high vs low) | 1.043 | 0.384 | 13.025 | 0.007 | 2.83 (1.34–6.02) |
Adjusting for potential confounding factors, including age, gender, smoking, drinking, hypertension, diabetes mellitus, BMI, TC, TG, LDL-C, HDL-C, hs-CRP, creatinine, uric acid, vessel lesions, and LVEF.